Acne Drug Accutane Pulled from U.S. Market
The acne drug Accutane, produced by Swiss company Roche, was pulled from the U.S. market after juries awarded over $30 million dollars to plaintiffs who filed lawsuits claiming a connection to using the drug with bowel disease, according to Bloomberg News. The controversy surrounding Accutane and its side effects isn’t new. The drug posed birth-defect…